PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
2.06%
Positive revenue growth while AVGO is negative. John Neff might see a notable competitive edge here.
4.38%
Positive gross profit growth while AVGO is negative. John Neff would see a clear operational edge over the competitor.
10.11%
EBIT growth below 50% of AVGO's 74.77%. Michael Burry would suspect deeper competitive or cost structure issues.
9.21%
Operating income growth under 50% of AVGO's 74.77%. Michael Burry would be concerned about deeper cost or sales issues.
7.23%
Net income growth under 50% of AVGO's 46.71%. Michael Burry would suspect the firm is falling well behind a key competitor.
6.98%
EPS growth under 50% of AVGO's 41.67%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
7.94%
Diluted EPS growth under 50% of AVGO's 45.45%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.21%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.31%
Reduced diluted shares while AVGO is at 0.72%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-0.06%
Dividend reduction while AVGO stands at 0.06%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
62.24%
OCF growth above 1.5x AVGO's 25.09%. David Dodd would confirm a clear edge in underlying cash generation.
76.64%
FCF growth above 1.5x AVGO's 25.04%. David Dodd would verify if the firm’s strategic investments yield superior returns.
101.87%
10Y revenue/share CAGR under 50% of AVGO's 815.05%. Michael Burry would suspect a lasting competitive disadvantage.
27.36%
5Y revenue/share CAGR under 50% of AVGO's 397.59%. Michael Burry would suspect a significant competitive gap or product weakness.
20.00%
3Y revenue/share CAGR under 50% of AVGO's 53.84%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
336.00%
10Y OCF/share CAGR under 50% of AVGO's 2078.22%. Michael Burry would worry about a persistent underperformance in cash creation.
164.88%
Below 50% of AVGO's 571.79%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
79.90%
3Y OCF/share CAGR under 50% of AVGO's 323.38%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
578.69%
Below 50% of AVGO's 1301.54%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
118.39%
5Y net income/share CAGR at 50-75% of AVGO's 176.51%. Martin Whitman might see a shortfall in operational efficiency or brand power.
70.62%
Below 50% of AVGO's 157.53%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
24.55%
Below 50% of AVGO's 1476.74%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
-7.32%
Negative 5Y equity/share growth while AVGO is at 344.45%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-8.78%
Negative 3Y equity/share growth while AVGO is at 11.12%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
602.36%
Dividend/share CAGR of 602.36% while AVGO is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
155.50%
Below 50% of AVGO's 882.76%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
102.39%
Below 50% of AVGO's 411.61%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
-1.46%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-2.44%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-0.34%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-0.17%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
0.10%
We have some new debt while AVGO reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
0.26%
R&D dropping or stable vs. AVGO's 1.59%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
1.45%
We expand SG&A while AVGO cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.